Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years as the country tackles a recent increase of infections.
"The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population," the health ministry said in a statement, adding, "its safety profile is also consistent with the known safety profile in the adult population."
The government will also extend the interval between two-dose COVID-19 vaccines to six to eight weeks, from three to four weeks currently, it said.
7 killed as 6.3 magnitude earthquake hits northern Afghanistan
Hamas hands over three more hostage bodies
Israeli strike kills one in Gaza as sides trade blame for truce violations
UK police say mass stabbing on train not terrorist incident, two arrested
Israel urges Lebanon to disarm Hezbollah under ceasefire terms
Russian attacks on Ukraine kill two
Kenya landslide death toll rises to 22
Fire at store in northwestern Mexico leaves at least 23 dead
